Globus Medical, Inc.
GMED
$91.70
-$2.10-2.24%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.46% | 3.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.46% | 3.18% | |||
| Cost of Revenue | 3.45% | 1.39% | |||
| Gross Profit | 9.35% | 4.05% | |||
| SG&A Expenses | 7.25% | -6.35% | |||
| Depreciation & Amortization | -1.62% | -1.15% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.46% | -2.91% | |||
| Operating Income | 17.96% | 32.24% | |||
| Income Before Tax | 17.53% | -23.48% | |||
| Income Tax Expenses | 14.43% | 270.57% | |||
| Earnings from Continuing Operations | 18.18% | -41.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.18% | -41.35% | |||
| EBIT | 17.96% | 32.24% | |||
| EBITDA | 11.69% | 21.10% | |||
| EPS Basic | 18.26% | -41.05% | |||
| Normalized Basic EPS | 14.40% | 33.57% | |||
| EPS Diluted | 15.92% | -40.94% | |||
| Normalized Diluted EPS | 13.34% | 33.98% | |||
| Average Basic Shares Outstanding | -0.07% | -0.52% | |||
| Average Diluted Shares Outstanding | 0.87% | -0.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||